BackCatabasis Pharmaceuticals Overview

Catabasis Pharmaceuticals Current Assets

Latest current assets for CATB: $250M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$253.55M

Peer trimmed avg / median

Loading

Catabasis Pharmaceuticals Current Assets History

Loading

Catabasis Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Catabasis Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Catabasis Pharmaceuticals (CATB) FAQ

The latest current assets for CATB is $250M as of September 2025. Investors often review this figure alongside Catabasis Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

A current assets figure of $250M for CATB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CATB's current assets ($250M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Catabasis Pharmaceuticals's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.